Clinical Trials Browser

Phase 2 × Has results × Advanced Malignancies × Clear all

NCT04949191 2024-09-19

The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.

Phase 2 Terminated

10 enrolled 9 charts

Advanced Malignancies